SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sanjay Varma who wrote (68)10/12/1996 11:45:00 AM
From: Josh C. Pleasure, M.D.   of 1501
 
The investment will entail issuing more shares (I didn't ask how many), but I still think it is a good thing. Mr. King stated that the venture fund would be receiving a slightly favorable price from the company but the understanding would be that they would be making additional purchases in the open market. I do not think that this fund will be selling shares unless there is some significantly bad news from the company. In that case, our shares would be going down anyway. Also, there will now be an institutional investor with deep pockets who obviously believes in the company that will be buying shares when prices are attractive. I feel that this will make a nice floor in the price of shares.

The fact that a biotechnology investment fund wants to invest in our company is good news! It reaffirms that IZP is on to something.

The market potential for IZP's drugs is huge. The extra cash from this investment will help them develop other drugs more quickly.

As far as your question about IZP's ability to run the clinical trial - that's what they hired that NJ company - I forget the name - to do for them. THis is a company that takes other companies drugs through the approval process. I'm sure that they are very good at it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News